Company Profile
Harpoon Therapeutics Stock Price, News & Analysis
- Ticker:
- HARP
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Why the stock is moving
Current closing-price context is not available for HARP.
Company overview
Business overview
Harpoon Therapeutics was an immuno-oncology company focused on T-cell engagers and related cancer therapies before being acquired. Its story was rooted in trying to create more precise immune activation in solid and hematologic tumors.
Geographic Base and Sector Classification
Harpoon was headquartered in the United States and listed on NASDAQ before the acquisition. It sat in oncology biotechnology.
Business Model Characteristics
The company depended on clinical data, safety management, and the ability to show that its immune-engagement platform could create meaningful anti-tumor activity. Investors watched readouts, differentiation, and strategic interest.
Position Within the Biotechnology Landscape
Harpoon was a catalyst-driven oncology biotech with strong platform ambition before acquisition. It now belongs to the historical M&A set rather than the live public-company universe.
Future catalysts
Harpoon Therapeutics is now a legacy / closeout story, so the catalysts are any final transaction or asset-resolution update. There is no active standalone pipeline left.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What does Harpoon Therapeutics do?
Harpoon Therapeutics was an immuno-oncology company focused on T-cell engagers and related cancer therapies before being acquired. Its story was rooted in trying to create more precise immune activation in solid and hematologic tumors.
On which exchange is HARP stock listed?
Harpoon Therapeutics (HARP) is associated with NASDAQ, United States, Biopharma.
What is Harpoon?
Harpoon Therapeutics is now a legacy / closeout story, so the catalysts are any final transaction or asset-resolution update.
Which conditions is Harpoon Therapeutics targeting with Harpoon?
Harpoon Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Harpoon Therapeutics describe recent progress with Harpoon?
Harpoon Therapeutics is now a legacy / closeout story, so the catalysts are any final transaction or asset-resolution update.
What is Therapeutics?
Harpoon Therapeutics was an immuno-oncology company focused on T-cell engagers and related cancer therapies before being acquired.
What should investors watch for with Therapeutics?
Harpoon Therapeutics is now a legacy / closeout story, so the catalysts are any final transaction or asset-resolution update.
What is T-cell?
Harpoon Therapeutics was an immuno-oncology company focused on T-cell engagers and related cancer therapies before being acquired.